GLP-1 Treatments
Dermatology Guide — April 2026

Ozempic Face Explained

What causes facial volume loss on GLP-1 medication, how to prevent it, and the treatment options available in the UK.

Key facts

  • "Ozempic face" is not a medical term — it describes facial volume loss from significant weight loss
  • It occurs with any form of major weight loss, not just GLP-1 medications
  • More noticeable in patients over 40 due to natural collagen decline
  • Gradual weight loss (0.5–1 kg/week) reduces severity compared to rapid loss
  • Multiple treatment options exist, from topical skincare to dermal fillers
  • Prevention is more effective than correction — protein, hydration and sun protection help

What is Ozempic face?

"Ozempic face" is a popular term that entered public consciousness around 2023 to describe the gaunt, hollow facial appearance some people develop after significant weight loss on GLP-1 receptor agonist medications. Despite its name, the phenomenon is not specific to Ozempic — it can occur with Wegovy, Mounjaro, Saxenda, or indeed any method of substantial weight loss including bariatric surgery or intensive dietary intervention.

The face contains multiple fat pads (malar, buccal, temporal, periorbital) that provide structure, volume and a youthful contour. When you lose a significant amount of body fat, facial fat pads also shrink. Unlike body fat, which many patients are happy to lose, facial fat provides an aesthetically important structural role. Its loss can make people look older, more tired or unwell — even when they are healthier than before.

What does Ozempic face look like?

The characteristic features include:

Why does it happen?

GLP-1 receptor agonists like semaglutide produce average weight loss of 15–22% of body weight. At these magnitudes, facial fat loss is essentially inevitable. Several factors determine severity:

Rate of weight loss

Rapid weight loss gives the skin less time to adapt. The STEP clinical trials documented most weight loss occurring in the first 40 weeks, with some patients losing 20+ kg in this period. This pace can outstrip the skin's ability to remodel. Gradual weight loss allows collagen and elastin fibres more time to contract and adapt to the new facial contours.

Age and skin quality

Collagen production declines by approximately 1% per year after age 25. By age 50, most people have lost 25–30% of their facial collagen. This means that patients over 40 have significantly less capacity for skin retraction after fat loss. Patients over 65 are at highest risk of pronounced facial volume depletion.

Genetics and ethnicity

Facial fat distribution and skin thickness vary by genetics and ethnicity. People with naturally rounder faces and more facial fat may notice more dramatic changes. Skin thickness and elasticity also have a strong genetic component.

Sun exposure history

Chronic UV exposure (photoageing) degrades collagen and elastin fibres in the dermis, reducing the skin's ability to retract. Patients with a history of significant sun exposure without protection are more likely to develop skin laxity after weight loss.

Smoking

Smoking accelerates collagen breakdown and impairs blood flow to the skin. Current and former smokers often experience more severe facial volume loss with a less favourable recovery.

Important perspective: Ozempic face is an aesthetic concern, not a medical complication. The health benefits of significant weight loss — reduced cardiovascular risk, improved blood sugar, lower cancer risk, better joint health — far outweigh cosmetic concerns for most patients. Discuss the balance of priorities with your prescriber.

Prevention strategies

Whilst complete prevention is unrealistic with significant weight loss, several evidence-based strategies can minimise the impact.

1. Protein intake

Adequate protein intake preserves lean tissue throughout the body, including facial muscles. Aim for 1.2–1.6 g of protein per kilogram of body weight daily. This also helps prevent generalised muscle loss, which can compound the gaunt appearance.

2. Gradual weight loss

The standard GLP-1 RA dose titration schedule (16–20 weeks to reach the full dose) naturally slows initial weight loss. Resist the temptation to escalate doses faster than recommended. If you are losing weight very rapidly (more than 1 kg per week consistently), discuss with your prescriber whether a dose adjustment might be appropriate.

3. Sun protection

Daily broad-spectrum SPF 30+ sunscreen on the face protects existing collagen from further UV damage. This is the single most important topical intervention for skin quality, regardless of GLP-1 use. Use a moisturiser with SPF daily, even in British winters.

4. Topical retinoids

Prescription retinoids (tretinoin) or over-the-counter retinol stimulate collagen production in the dermis. Starting a retinoid alongside GLP-1 treatment gives the skin the best chance of maintaining structural integrity during weight loss. Begin with a low concentration and build up gradually to avoid irritation.

5. Hydration

Adequate water intake (2–2.5 litres daily) and topical hyaluronic acid serums help maintain skin hydration and plumpness. Dehydration, which can worsen with GLP-1 side effects like vomiting and diarrhoea, accelerates the hollow appearance.

6. Facial exercises

Resistance-based facial exercises may help maintain tone in the muscles underlying facial fat pads. Evidence is limited but growing. Exercises targeting the cheeks, jawline and around the eyes can be performed daily and carry no risk.

Proactive approach: Start prevention strategies at the same time you begin GLP-1 medication, not after facial changes become visible. Collagen preservation is far more effective than collagen rebuilding.

Treatment options in the UK

If facial volume loss has already occurred, several treatments can restore a more youthful contour. All aesthetic procedures should be performed by qualified practitioners. In England, non-surgical cosmetic procedures are regulated, and from 2025 practitioners must be licensed by the CQC for Botox and dermal filler treatments.

Treatment Mechanism Duration of effect Approx. UK cost
Hyaluronic acid fillers (Juvéderm, Restylane) Direct volume replacement 12–18 months £300–£600 per syringe
Sculptra (poly-L-lactic acid) Stimulates collagen production Up to 25 months £300–£500 per vial
Profhilo Deep skin hydration, biostimulation 6–9 months £250–£400 per session
Radiofrequency skin tightening Collagen contraction and remodelling 12–18 months £200–£500 per session
HIFU (high-intensity focused ultrasound) Deep tissue tightening 12–18 months £500–£1,500 per session
Facelift (surgical) Surgical skin and tissue repositioning 5–10+ years £7,000–£12,000
Fat transfer Autologous fat grafting to face Variable (50–70% graft survival) £3,000–£6,000

Dermal fillers: the most popular option

Hyaluronic acid (HA) dermal fillers are the most commonly requested treatment for Ozempic face in the UK. They provide immediate volume restoration with minimal downtime. Key treatment areas include the cheeks (malar region), temples, tear troughs (under-eyes), nasolabial folds and jawline.

Most patients require 2–4 syringes for meaningful correction. Results are visible immediately and typically last 12–18 months before gradual reabsorption. HA fillers have the advantage of being dissolvable with hyaluronidase if the result is unsatisfactory.

Sculptra: the collagen stimulator

For patients who prefer a more gradual, natural-looking result, Sculptra (poly-L-lactic acid) stimulates the body's own collagen production over 2–3 months. A course typically involves 2–3 sessions spaced 4–6 weeks apart, with results lasting up to 25 months. Sculptra is particularly effective for diffuse volume loss across the mid-face and temples.

Choose your practitioner carefully: Always verify that your aesthetic practitioner is appropriately qualified and registered. Check the CQC register (England), or equivalent regulatory bodies in Scotland, Wales and Northern Ireland. Avoid unregistered practitioners offering treatments at significantly reduced prices.

When to worry

Ozempic face is an aesthetic concern, not a medical emergency. However, certain signs alongside facial changes warrant medical attention:

Ozempic face versus other weight loss methods

It is worth reiterating that facial volume loss is a consequence of weight loss, not of GLP-1 medication specifically. Patients who lose equivalent amounts of weight through bariatric surgery, very low-calorie diets or intensive exercise programmes experience the same facial changes.

However, GLP-1 RAs produce relatively rapid weight loss (typically 15–22% over 12–18 months), which may make facial changes more noticeable compared to slower weight loss methods. The magnitude of loss is also greater than most patients achieve through lifestyle interventions alone, meaning the facial impact is more pronounced.

Frequently asked questions

What is Ozempic face?

A colloquial term for facial volume loss — hollowed cheeks, deepened lines and sagging skin — that occurs after significant weight loss on GLP-1 medications. It happens with any substantial weight loss, not just Ozempic.

Can you prevent Ozempic face?

You can reduce its severity through gradual weight loss, adequate protein intake (1.2–1.6 g/kg daily), sun protection (SPF 30+ daily), topical retinoids, hydration and facial exercises. Complete prevention is difficult with large amounts of weight loss.

What treatments are available in the UK?

Hyaluronic acid dermal fillers (most popular), Sculptra (collagen stimulation), Profhilo (skin hydration), radiofrequency or HIFU skin tightening, and surgical options (facelift, fat transfer). Choose a CQC-registered practitioner.

Does Ozempic face go away on its own?

Partial improvement may occur as the skin adapts over 6–12 months after weight stabilises. However, lost facial fat pads do not fully regenerate. Younger patients recover better than those over 40.

At what age is Ozempic face more noticeable?

Facial volume loss is most pronounced in patients over 40, as natural collagen decline and reduced skin elasticity mean the face cannot adapt as well. Patients in their 20s and 30s typically have better recovery.

Is Ozempic face a reason to avoid treatment?

For most patients, no. The health benefits of significant weight loss — reduced cardiovascular risk, improved metabolic health, better joint function — far outweigh aesthetic concerns. Discuss your priorities with your prescriber and consider starting prevention strategies early.

Related guides

Sources